177 related articles for article (PubMed ID: 23925934)
61. Expression of cholera toxin B-proinsulin fusion protein in lettuce and tobacco chloroplasts--oral administration protects against development of insulitis in non-obese diabetic mice.
Ruhlman T; Ahangari R; Devine A; Samsam M; Daniell H
Plant Biotechnol J; 2007 Jul; 5(4):495-510. PubMed ID: 17490448
[TBL] [Abstract][Full Text] [Related]
62. DNA fusion vaccines induce targeted epitope-specific CTLs against minor histocompatibility antigens from a normal or tolerized repertoire.
Rice J; Buchan S; Dewchand H; Simpson E; Stevenson FK
J Immunol; 2004 Oct; 173(7):4492-9. PubMed ID: 15383580
[TBL] [Abstract][Full Text] [Related]
63. Sublingual tolerance induction with antigen conjugated to cholera toxin B subunit induces Foxp3+CD25+CD4+ regulatory T cells and suppresses delayed-type hypersensitivity reactions.
Sun JB; Cuburu N; Blomquist M; Li BL; Czerkinsky C; Holmgren J
Scand J Immunol; 2006 Sep; 64(3):251-9. PubMed ID: 16918694
[TBL] [Abstract][Full Text] [Related]
64. Vaccination with empty plasmid DNA or CpG oligonucleotide inhibits diabetes in nonobese diabetic mice: modulation of spontaneous 60-kDa heat shock protein autoimmunity.
Quintana FJ; Rotem A; Carmi P; Cohen IR
J Immunol; 2000 Dec; 165(11):6148-55. PubMed ID: 11086048
[TBL] [Abstract][Full Text] [Related]
65. Mechanisms of regulatory T-cell induction by antigen-IgG-transduced splenocytes.
Wang R; Song L; Han G; Wang J; Chen G; Xu R; Yu M; Qian J; Shen B; Li Y
Scand J Immunol; 2007 Nov; 66(5):515-22. PubMed ID: 17883389
[TBL] [Abstract][Full Text] [Related]
66. Immunization with the larger isoform of mouse glutamic acid decarboxylase (GAD67) prevents autoimmune diabetes in NOD mice.
Elliott JF; Qin HY; Bhatti S; Smith DK; Singh RK; Dillon T; Lauzon J; Singh B
Diabetes; 1994 Dec; 43(12):1494-9. PubMed ID: 7525393
[TBL] [Abstract][Full Text] [Related]
67. Plant-based vaccines for oral delivery of type 1 diabetes-related autoantigens: Evaluating oral tolerance mechanisms and disease prevention in NOD mice.
Posgai AL; Wasserfall CH; Kwon KC; Daniell H; Schatz DA; Atkinson MA
Sci Rep; 2017 Feb; 7():42372. PubMed ID: 28205558
[TBL] [Abstract][Full Text] [Related]
68. Characterization of an internal permissive site in the cholera toxin B-subunit and insertion of epitopes from human immunodeficiency virus-1, hepatitis B virus and enterotoxigenic Escherichia coli.
Bckström M; Holmgren J; Schödel F; Lebens M
Gene; 1995 Nov; 165(2):163-71. PubMed ID: 8522171
[TBL] [Abstract][Full Text] [Related]
69. Immunization of non-obese diabetic (NOD) mice with glutamic acid decarboxylase-derived peptide 524-543 reduces cyclophosphamide-accelerated diabetes.
Saï P; Rivereau AS; Granier C; Haertlé T; Martignat L
Clin Exp Immunol; 1996 Aug; 105(2):330-7. PubMed ID: 8706342
[TBL] [Abstract][Full Text] [Related]
70. Transcutaneous immunization with cholera toxin B subunit adjuvant suppresses IgE antibody responses via selective induction of Th1 immune responses.
Anjuère F; George-Chandy A; Audant F; Rousseau D; Holmgren J; Czerkinsky C
J Immunol; 2003 Feb; 170(3):1586-92. PubMed ID: 12538724
[TBL] [Abstract][Full Text] [Related]
71. Oral tolerization with peptide 336-351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease.
Stanford M; Whittall T; Bergmeier LA; Lindblad M; Lundin S; Shinnick T; Mizushima Y; Holmgren J; Lehner T
Clin Exp Immunol; 2004 Jul; 137(1):201-8. PubMed ID: 15196263
[TBL] [Abstract][Full Text] [Related]
72. Dermal enhancement: bacterial products on intact skin induce and augment organ-specific autoimmune disease.
Riminton DS; Kandasamy R; Dravec D; Basten A; Baxter AG
J Immunol; 2004 Jan; 172(1):302-9. PubMed ID: 14688338
[TBL] [Abstract][Full Text] [Related]
73. Oral tolerance revisited: prior oral tolerization abrogates cholera toxin-induced mucosal IgA responses.
Kato H; Fujihashi K; Kato R; Yuki Y; McGhee JR
J Immunol; 2001 Mar; 166(5):3114-21. PubMed ID: 11207263
[TBL] [Abstract][Full Text] [Related]
74. Coupling of oral human or porcine insulin to the B subunit of cholera toxin (CTB) overcomes critical antigenic differences for prevention of type I diabetes.
Petersen JS; Bregenholt S; Apostolopolous V; Homann D; Wolfe T; Hughes A; De Jongh K; Wang M; Dyrberg T; Von Herrath MG
Clin Exp Immunol; 2003 Oct; 134(1):38-45. PubMed ID: 12974752
[TBL] [Abstract][Full Text] [Related]
75. Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells.
Grewal IS; Grewal KD; Wong FS; Picarella DE; Janeway CA; Flavell RA
J Exp Med; 1996 Nov; 184(5):1963-74. PubMed ID: 8920883
[TBL] [Abstract][Full Text] [Related]
76. Reversal of type 1 diabetes by a new MHC II-peptide chimera: "Single-epitope-mediated suppression" to stabilize a polyclonal autoimmune T-cell process.
Lin M; Stoica-Nazarov C; Surls J; Kehl M; Bona C; Olsen C; Brumeanu TD; Casares S
Eur J Immunol; 2010 Aug; 40(8):2277-88. PubMed ID: 20540111
[TBL] [Abstract][Full Text] [Related]
77. Enhancing Antigen Presentation and Inducing Antigen-Specific Immune Tolerance with Amphiphilic Peptides.
Li M; Itoh A; Xi J; Yu C; Wu Y; Ridgway WM; Liu H
J Immunol; 2021 Oct; 207(8):2051-2059. PubMed ID: 34526376
[TBL] [Abstract][Full Text] [Related]
78. Evidence for early aging in the mucosal immune system.
Koga T; McGhee JR; Kato H; Kato R; Kiyono H; Fujihashi K
J Immunol; 2000 Nov; 165(9):5352-9. PubMed ID: 11046071
[TBL] [Abstract][Full Text] [Related]
79. The Nontoxic Cholera B Subunit Is a Potent Adjuvant for Intradermal DC-Targeted Vaccination.
Antonio-Herrera L; Badillo-Godinez O; Medina-Contreras O; Tepale-Segura A; García-Lozano A; Gutierrez-Xicotencatl L; Soldevila G; Esquivel-Guadarrama FR; Idoyaga J; Bonifaz LC
Front Immunol; 2018; 9():2212. PubMed ID: 30319653
[TBL] [Abstract][Full Text] [Related]
80. Sublingual 'oral tolerance' induction with antigen conjugated to cholera toxin B subunit generates regulatory T cells that induce apoptosis and depletion of effector T cells.
Sun JB; Czerkinsky C; Holmgren J
Scand J Immunol; 2007; 66(2-3):278-86. PubMed ID: 17635805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
